Meyka Pro banner
Metall Zug AG

Metall Zug AG (SIX: METN.SW) Stock Competitors & Peer Comparison

See METN.SW's competitors and their performance on the SIX and across the wider stock market.

METN.SWSIX
HealthcareMedical - Devices
CHF865.00
CHF1.00(0.12%)
Swiss Market opens in 0h 9m

Peer Comparison Table: Medical - Devices Industry

Detailed financial metrics including price, market cap, P/E ratio, and more for METN.SW and its SIX peers.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
METN.SWCHF 865.00+0.12%387.5M-35.95-CHF 24.06N/A
ABT.SWCHF 72.50-2.68%125.5B19.79CHF 3.66+2.70%
ZBH.SWCHF 77.50+24.00%15B12.53CHF 6.19+0.99%
SOON.SWCHF 237.00+2.16%14.1B26.04CHF 9.10+1.98%
MED.SWCHF 86.50+2.00%1.1B72.08CHF 1.20N/A

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

Abbott Laboratories (SIX: ABT.SW)

METN.SW vs ABT.SW Comparison September 2026

Metall Zug AG (SIX: METN.SW) plays a significant role within the Healthcare sector. Its performance on the SIX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, METN.SW stands at 387.5M. In comparison, ABT.SW has a market cap of 125.5B. Regarding current trading prices, METN.SW is priced at CHF 865.00 on the SIX, while ABT.SW trades at CHF 72.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

METN.SW currently has a P/E ratio of -35.95, whereas ABT.SW's P/E ratio is 19.79. In terms of profitability, METN.SW's ROE is -0.03%, compared to ABT.SW's ROE of +0.11%. Regarding short-term risk, METN.SW is more volatile compared to ABT.SW. This indicates higher risk in terms of short-term price fluctuations for METN.SW.Check ABT.SW's competition here

Stock price comparison of stocks in the Healthcare Sector

Loading...

Frequently Asked Questions